# Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity

> **NCT06215196** · NA · COMPLETED · sponsor: **S.LAB (SOLOWAYS)** · enrollment: 81 (actual)

## Conditions studied

- Overweight and Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** Fiber Supplement Group
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT06215196
- **Lead sponsor:** S.LAB (SOLOWAYS)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-14
- **Primary completion:** 2023-06-28
- **Final completion:** 2023-08-20
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2024-01-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06215196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06215196, "Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06215196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*